advanced resources to treat cerebral aneurysms and to manage the problems associated with this disorder.
In studies evaluating the relationship between hospital case volume of SAH and mortality rates, investigators have increasingly found an association. 12, 26, 28 The authors of these studies have not attempted to control for differences in pretreatment prognosis for patients admitted to high-compared with low-volume centers, have limited their investigations to particular types of hospitals, or have drawn on data from a single state. Our objective was to test the hypothesis of a hospital SAH volume-mortality rate relationship in a large administrative data set representing all admissions for SAH in 18 states while controlling for the admission source, patient demographics, and comorbidities.
Clinical Material and Methods

Data Source and Case Selection
We performed a retrospective analysis by using hospital discharge databases from 18 states representing 58% of the US population. Databases were purchased from state data organizations (California and Florida) and HealthShare Technology, Inc., (Acton, MA) (Colorado, Illinois, Iowa, Maryland, Massachusetts, Nevada, New Hampshire, New Jersey, New York, Oregon, Pennsylvania, Texas, Utah, Vermont, Virginia, and Wisconsin). These databases represent 100% of all inpatient hospitalizations from non-Federal, acute-care hospitals in each state, and contain information such as diagnoses, procedures, admission sources, discharge destinations, patient demographics, and admitting hospital name for each hospitalization. The most recent annual data available from each state at the time of purchase was used. Thirteen of the 18 states' data were from 1999; New Hampshire and New Jersey's data were from 1998; and Colorado, Iowa, and Nevada's data were from 2000.
We identified hospitalizations for SAH by searching the principal and all secondary diagnosis fields for the ICD-9-CM diagnosis code for SAH (430.0). Records specifying secondary diagnoses of AVM (code 747.81) or head trauma (800-803.9 and 850-854.9), or procedures for arteriovenous fistula repair (39.53) or radiosurgery (92.30) were excluded from the analysis. 12 We excluded records from rehabilitation hospitals and those of patients whose length of stay was 1 day or less when the discharge destination was home. The length-of-stay exclusion criterion was applied to eliminate patients who may have been misclassified as suffering from SAH, because patients with true SAH would stay in the hospital for a longer period before being discharged home. For all statistical analyses, we also removed all patients with missing covariates.
To control for case severity, we limited the main analysis to hospitalizations for which admission was through the emergency department with an emergency or urgent admission type. This stipulation attempts to avoid confounding arising from a referral bias (that is, patients transferred to centers with large volumes of SAH cases may not have the same prognosis as those admitted urgently through the emergency department). Each hospitalization was assumed to represent an individual patient, because these data contained no patient identifiers that would allow tracking of repeated hospitalizations or transfers to other hospitals. Patients with "transferred" listed as their discharge status were retained for analysis, and conservatively assigned to the "alive at discharge" group. Therefore, this method likely underestimates the actual mortality rate for hospitals that transfer a large percentage of patients. Also, we defined "hospital transfer" cases according to two different definitions because of variations in hospital reporting standards in different states. For the first, any discharge describing a transfer to another acute-care facility in a patient who did not have a definitive aneurysm treatment was counted as a hospital transfer case. For the second, the same definition was used, but with additional discharge status values of "other," "unknown," and "other facility."
Incidence Rate Calculations
For comparisons with nationally reported SAH incidence rates, we computed rates from our database by first estimating the total number of SAH cases in the US (dividing the numbers of patients with SAH by the percentage of the US population that the 18 states represent, 58%), and then dividing the result by the total US population (272,690,813) in 1999. We computed three separate incidence rates of SAH by using different sample sizes based on all records of patients with a diagnosis of SAH, the number remaining after exclusion criteria were implemented, and all patients with SAH who were not admitted as transfer patients.
Model Variables and Outcomes
The variables in our analyses included patient age (in quartiles), sex, Medicaid status, hospital region, data source year, hospital SAH case volume quartile, and comorbidity index score. We used patient age quartile rather than age in years because there was a nonlinear relationship between outcomes and age in years. The hospital region was included to control for regional variations in practice. The primary outcome of interest was in-hospital deaths, which was identified using the discharge status of "expired." Hospital treatment and transfer rates were also compared across SAH case volume quartiles in univariate analyses.
We defined the hospital SAH case volume variable a priori by first counting the total number of patients with SAH after inclusion and exclusion criteria were applied but before controlling for disease severity (urgent emergency department admissions). In other words, a hospital's SAH case volume was based on admissions from all sources: emergency department, transfer, home, and so on. These patients were then distributed into four relatively equal hospital volume groups (quartiles). Choosing quartiles based only on emergency department admissions would have inappropriately categorized as smaller-volume centers the larger-volume hospitals that received more of their patients as transfer admissions. We had no hypothesis about the relationship between the number of SAH cases a hospital admits per year and its rate of in-hospital mortality, and we let the data determine the quartiles. 15 Quartiles 1, 2, 3, and 4 contained hospitals with annual admissions of one to nine, 10 to 18, 19 to 35, and 36 to 158 patients with SAH, respectively.
Patients with definitive SAH treatment were identified using ICD-9 procedure codes for both surgical (codes 01.24, 38.31, 38.61, and 39.51) and endovascular approaches (38.81 and 39.52). We calculated treatment rates by us-ing several different definitions: 1) any definitive treatment; 2) surgery only; 3) endovascular treatment only; and 4) any definitive treatment or transfer to another hospital. We also used the endovascular ICD-9 procedure codes to identify facilities with endovascular services for treating SAH. Admission rates for patients with SAH to facilities with endovascular services were then compared across hospital volume quartiles in univariate analyses.
Comorbidity Index
To control further for disease severity, we developed a comorbidity index by using only patients with SAH who were admitted through the emergency department. From a list of comorbid conditions generated from these patients' records, we chose the following diagnoses (ICD-9-CM codes) as inputs into a backward stepwise logistic regression model on 67% of our data: diabetes with complications (250-250.1), diabetes without complications (250.1-260), malignant hypertension (401-401.1), benign hypertension (401.1-402), hypertensive renal disease (403-404), heart disease (412-415), cardiac valvular disease (424-425), atrial fibrillation (427.3-427.4), congestive heart failure (428.0-428.1), chronic pulmonary disease (493-494, 496-497), and history of malignant neoplasm (V10-V11). Statistically significant predictors of death were included in a GEE model. The beta coefficients from the GEE model were used to obtain a comorbidity index score for each patient. The comorbidity scores from the remaining third of the data were validated by demonstrating a similar association with in-hospital deaths after SAH. The comorbidity score was included in all subsequent GEE models. For presentation purposes, we converted comorbidity scores to predicted death rates due to comorbid conditions. These predicted values are a function of the beta coefficients, which were calculated using commercially available software (version 8; SAS Institute, Inc., Cary, NC).
Statistical Analysis
Univariate analyses were used to compare means or proportions across the quartiles of hospital SAH case volume using one-way analysis of variance or chi-square tests as appropriate. To adjust the in-hospital mortality outcome for potential confounding factors, multivariate techniques were needed; we used GEEs. This technique allows modeling of the relationship between in-hospital mortality and hospital SAH case volume quartile, with simultaneous adjustment for multiple confounding factors. The GEE method also has the advantage of allowing adjustment of the correlation between observations or nonindependence of observations. In these analyses, one might presume some clustering of treatment practices and subsequent outcomes within each hospital, making the "within-hospital" observations correlated, and not independent; we can adjust for such clustering by using GEEs. Practically speaking, such an adjustment usually has the effect of widening the CI of a risk estimate (such as the OR), leading to more conservative conclusions. 23 All GEE models used in-hospital deaths as the dichotomous outcome, adjusted for "within-hospital" correlation, age quartile, sex, hospital region, and data source year. The highest SAH case volume quartile, Quartile 4, was used as the reference. Treatment for SAH is described in the univariate analyses but is not included in the multivariate models. This was done because of the likelihood of confounding by indication, where the patient's condition and prognosis might determine whether they receive treatment. A hypothetical example from these data might be that patients being transferred to other hospitals, in reasonable condition and ready for definitive surgical care, would be counted as having had "no treatment" for the transferring institution, biasing that hospital's results so that it has an inflated mortality rate.
Results
Characteristics of the Database
A total of 17,896 records contained an SAH diagnosis code. The following records were not used as a result of our exclusion criteria: secondary diagnoses of AVM (217 cases) or head trauma (249); procedures for AVM repair (48) or radiosurgery (two); records from rehabilitation hospitals (730); and those of patients whose length of stay was 1 day or less who were discharged to home (251). A total of 16,399 patients with SAH remained after the exclusion criteria were applied. These patients were admitted to one of 1546 hospitals. The demographic characteristics of the patients in the database are representative of the epidemiological features of SAHs. The mean age, percentage of patients who were female, and percentage receiving Medicaid were 57 Ϯ 17.2 years, 62.8%, and 10.4%, respectively, compared with 57.3 years, 63.4%, and 11.8% nationally. 10 More than 37% of all patients with SAH were admitted to hospitals that had endovascular procedure capability. More than half (58.2%) of all patients with SAH were admitted through the emergency department, whereas 21.6% were admitted from other hospitals as transfer cases. The remaining patients were admitted from other sources, such as long-term care facilities, home, referrals, and so on. Approximately 27% of all patients with SAH died in the hospital, whereas 13.6% were transferred to another acute-care facility. (When we expanded the definition of "hospital transfers" to include "other," "other facility," and "unknown," the percentage of patients discharged as hospital transfers was 26.8%.) Thirty-four percent of all patients admitted were treated using surgical or endovascular procedures. Additional descriptive results are presented in Table 1 .
The US incidence rates of SAH (for hospital admissions) were found to be between 8 and 11.2 per 100,000 according to the 18-state discharge database projects. If the complete database (all diagnoses of SAH before any exclusion criteria; 17,896 cases) is used, by extrapolation the national incidence estimate is 30,539 or 11.2 per 100,000. The sample of 16,399 patients with SAH translates into a national incidence estimate of 27,985 (10.3 per 100,000). This sample excludes trauma cases, admissions to rehabilitation hospitals, and patients who did not die but stayed only 1 day or less. A more conservative estimate and one that would provide a better approximation of the number of patients admitted for SAH would eliminate those admitted by transfer, because these individuals have already been counted at the hospital where they were initially admitted. The national estimate for nontransferred patients (12,857 in our sample) is 21,940 (eight per 100,000). These results compare favorably with US estimates from other databases. 10, 22 These results provide an overall picture of all patients with SAH in our 18-state database. All statistical analyses, however, focused on a subgroup of patients who did not have missing covariates (16, 116) , were admitted through the emergency department (9379), and had an emergency or urgent admission type (9290). The remaining univariate and multivariate results focus on this last subgroup of 9290 patients with SAH.
Comorbidity Index
The comorbidity index was derived from 6224 patients admitted through the emergency department (67% of 9290). Malignant hypertension, benign hypertension, hypertensive renal disease, heart disease, atrial fibrillation, and congestive heart failure were all statistically significant predictors of death in patients with SAH (Table 2) . Beta coefficients from these significant predictors were summed to obtain a comorbidity index score for each patient, and these scores were strongly associated with in-hospital deaths. The scores ranged from 0 to 1.854 (predicted rates of death from comorbid conditions ranged from 0.29 to 0.72). A GEE model containing the comorbidity index score and all of the other independent variables had an associated C statistic of 0.57 in the derivation subset and 0.54 in the validation subset.
Univariate Associations Across Hospital Volume Quartiles
Patients in the final analysis cohort presented with SAH (Table 3) . Patients with SAHs who were admitted to low-volume hospitals tended to be older (mean age 63 Ϯ 18 years) on average than those treated at higher-volume hospitals. Low-volume hospitals also had a lower proportion (7.5%) of Medicaid patients. Mortality rates were higher in the Midatlantic region (36.9%) compared with the West (31.6%), the South (31.6%), and New England (29.07%). Significantly higher in-hospital mortality rates (p Ͻ 0.0001) were seen at low-volume hospitals (Quartile 1, 38.7%; Quartile 2, 34.7%; Quartile 3, 30.8%; Quartile 4, 27%). There were small but statistically significant differences in the predicted number of deaths from comorbid conditions across hospital volume quartiles. In lower-volume centers the patients seemed to have slightly higher scores. The difference between the observed mortality rate and the death rate predicted by comorbid conditions was 4.7 in Quartile 1, 1.7 in Quartile 2, Ϫ2.2 in Quartile 3, and Ϫ5 in Quartile 4. Low-volume hospitals had significantly lower (p Ͻ 0.0001) treatment rates (Quartile 1, 12.6%; Quartile 2, 26.6%; Quartile 3, 32.4%; and Quartile 4, 45.8%). Lower-volume centers transferred a larger percentage of patients who had not received treatment than did the highest-volume centers (22.1 compared with 4%), but the combined rate of treated and transferred patients at the lowest-volume centers remained below the treatment rate for centers with the highest volume (34.7 compared with 45.8%). (When we expanded the definition of hospital transfer cases to include those with a discharge status of "other," "other facility," and "unknown," the transfer percentages increased by 4-5% in each hospital volume quartile.) Low-volume centers were extremely unlikely to offer endovascular services: only 2.1% of all patients in the lowest-volume quartile were admitted to hospitals that offered endovascular services, compared with 61% of the patients treated in the high-volume centers. Overall, 22.8% of patients admitted through an emergency department presented to centers that offered endovascular care.
Results of Multivariate Analysis
Multivariate GEEs were used to model the relationship between hospital volume and mortality rates after SAH, controlling for patient age, sex, Medicaid status, database year, and comorbid conditions. Patients who present to hospitals that admit one to nine patients with SAH per year (Quartile 1) have an odds of in-hospital death that is 1.4 (95% CI 1.2-1.6) times the odds of those who present to hospitals that admit more than 35 patients with SAH per year. The OR of dying in the hospital in each of the other volume quartiles was also increased (Quartile 2 OR 1.3, 95% CI 1.1-1.5). Quartile 3 had a comparative mortality rate of 1.1, although the CI overlapped with the fourth quartile (95% CI 0.98-1.3). The multivariate-adjusted results are presented in Fig. 1 .
Discussion
Mortality Rate/Case Volume Associations and Implications
These data show an association between in-hospital deaths after SAH and the volume of patients admitted to acute-care hospitals serving 58% of the US population. This association holds even after controlling for baseline patientlevel and hospital-level differences. In the lowest SAH case volume hospital quartile the mortality rate was 1.4 times that of the highest quartile. Taking comorbid conditions into account, low-volume hospitals had higher mortality rates than predicted, whereas the rates in high-volume hospitals were lower than predicted. These data also show a relationship (without controlling for other variables) between cerebral aneurysm treatment rate and SAH case volume. Patients admitted with acute SAH more often underwent craniotomy and clip occlusion or endovascular treatment of a ruptured cerebral aneurysm at a hospital with a high volume of SAH admissions than at one with a low volume of such admissions.
The short-term mortality rate after SAH is better today (33% in-hospital mortality rate in the univariate analysis of emergency department admissions in this study) than in 1966 (50% 29-day mortality rate in the Cooperative Study for SAH due to a single aneurysm 20 ). The difference in mortality rates among the hospital groups in this analysis is probably due to differences in the care rendered. The variance in mortality rates may relate to the training, skill, and experience of the people involved in the care of these patients, and it probably also relates to how the hospitals are equipped. Subspecialists including cerebrovascular neurosurgeons, interventional neuroradiologists, neuroanesthesiologists, and neurointensivists are more likely to be on the staff at higher-volume hospitals. Higher-volume hospitals are also more likely to have nurses in the operating room, as anesthetists, and in the intensive care unit who are experienced in the care of patients with cerebral aneurysms. Higher-volume hospitals are more likely to have a large inventory of aneurysm clips and of endovascular devices to treat aneurysms, dedicated biplane neurointervention rooms, and intraoperative angiographic equipment. Highervolume hospitals are more likely to have a defined, team approach to the care of patients with SAH. These factors may help account for the difference in mortality rates between higher and lower SAH case volume hospitals.
Treatment/Case Volume Associations and Implications
The higher rate of definitive treatment found at high SAH case volume hospitals was striking. Not only is definitive treatment linked to reduced rates of aneurysm rebleeding, but the higher treatment rate indicates that high SAH case volume hospitals are more likely to use their larger array of techniques, skills, and equipment when treating patients with this disorder. Given the clinical benefits of definitive aneurysm treatment and the techniques, equipment, and skills likely to be present at high volume centers, the rate of definitive aneurysm treatment seems low (45.8%). There are probably many reasons for the rate of treatment found at these centers. First, not all patients admitted with spontaneous acute SAH have cerebral aneurysms. The percentage of patients with acute SAH who did not have an aneurysm demonstrated on cerebral angiography was 50% in the 1966 Cooperative Study, but not all those angiographic examinations were complete. Studies in which all cerebral vascular territories were evaluated in multiple projections with the aid of today's imaging equipment showed that the percentage of patients with SAH who do not have a cerebral aneurysm ranges from 4 to 37%. 7, 21, 27, 29, 32 That is not sufficient to account for all the untreated patients, but it does cover a portion of them. Because some patients suffer SAH from causes other than a cerebral aneurysm, individuals admitted with a secondary code for trauma, AVM, radiosurgery, or AVM resection were excluded from this analysis, but it is possible that some miscoding occurred. Miscoding may also partly account for a lower observed than actual treatment rate. Patients with cerebral aneurysm rupture may not undergo definitive treatment because of very poor medical condition, and that group may also account for some of the untreated patients.
The reason for the variation in aneurysm treatment rates observed among hospital quartiles is probably a function of the differences in the willingness and ability of the various hospital groups to perform surgical or endovascular treatment, rather than a function of what fraction of patients with SAH are found to have an aneurysm. The percentage of patients presenting to an emergency department with SAH not related to an aneurysm would not be expected to vary with hospital case volume; however, the capability of different hospital groups to treat aneurysms is quite likely to vary. Low-and high-volume centers might treat an equal fraction of patients with aneurysms that are easily repaired, but the high-volume centers might treat a higher fraction of patients with aneurysms that are more difficult to repair. 31 Greater aggressiveness in and effectiveness of aneurysm treatment in high-volume centers may help to explain the lower mortality figures observed in those centers.
Comparison With Previous Studies
A relationship between case volume and outcome was observed in previous studies of other diseases, events, and procedures. 1, [3] [4] [5] [6] 8, 11, [16] [17] [18] [19] 24, 25, 30 In one study in which a New York state database was used, the investigators found a relationship between the mortality rate and hospital case volume for aneurysm clip occlusion, but did not look specifically at patients presenting with SAH. 26 Another study in which a California database was used and in which all admissions for SAH from 1990 through 1999 were examined is most comparable to the research presented in this paper. A statistically significant relationship between SAH case volume and mortality rates was also found. 2 The percentage of patients who were admitted through emergency departments with a diagnosis of SAH and who did not receive definitive surgical or endovascular aneurysm treatment was high in this study (70% overall, ranging from 54% at hospitals in the highest case volume quartile to 87% at hospitals in the lowest quartile). Similar numbers have been published before. A study of acute SAH admissions to more than 80 university hospitals found that 43% of patients did not receive definitive aneurysm treatment. 13 A study of acute SAH admissions to all California hospitals found that 71% did not have definitive aneurysm treatment. 2 
Study Limitations
This analysis depends entirely on retrospective data that were identified based on hospital coding. Retrospective data set analysis allows potential biases to exist that are difficult to control. For example, hospital coding for SAH (ICD-9 code 430) has no modifiers to indicate the severity of the patient's condition after the subarachnoid bleeding. To attempt to control for disease severity, this analysis was limited to cases designated in the records as admissions from the original hospital's emergency department. This should eliminate patients with predictably better prognoses, such as those admitted from home, those admitted directly from a physician's office, and those transferred from one hospital to another for definitive aneurysm treatment. Another explanation for the increased mortality rate at smaller-volume hospitals might be that patients admitted to smaller hospitals are sicker. There were slight differences in comorbidities, and patients initially seen at lower-volume hospitals had a slightly greater comorbidity burden, but after controlling for this in the multivariate analysis it explained little of the mortality level, and the more important factor was volume. It is possible that further comorbidity differences exist that we were not able to control for using by this administrative data.
There are other potential sources of error in database research. First, there is the possibility that patients' records were misclassified. For example, some patients who were transferred from one hospital to another may have been classified as emergency department admissions rather than as transfers if they were admitted through the receiving hospital's emergency department. Second, the data sets from states that were used in this analysis provided information on in-hospital deaths only. Tracking the full course of an individual patient's treatment, especially for those transferred to another hospital or care facility, would provide more complete information about the overall mortality rates for patients presenting to hospitals in each of the quartile groups. In our analysis, patients who were transferred were counted as "alive at discharge." Because a much larger proportion of patients at hospitals with smaller SAH case volumes were transferred compared with high-case volume centers, this method probably underestimated the actual mortality rate for patients who presented at the smallercase volume hospitals. In a California study in which they were able to track patients with SAH who were transferred to other facilities, researchers found a similar relationship between mortality rate and hospital SAH case volume. 2 Outcome assessment in this study was limited to in-hospital deaths. Functional outcome at a fixed time interval after SAH would be the optimal outcome measure, but information about such high-quality outcomes are not available from administrative data sets.
Systematic misdiagnosis may be a more significant problem. Hospitals with smaller SAH case volumes are less likely to have the sophisticated imaging equipment that facilitates both diagnosis and treatment. The fact that these hospitals admit fewer cases means that they get less practice in diagnosing the condition. Judging from the high mortality rates found in this study, it is clear that these patients are being admitted with a serious medical condition and that hospitals with higher case volumes are more successful in reducing patient deaths. If a lack of certainty about the diagnosis is affecting medical outcomes, it argues for diagnosing and treating cases at centers that have a better capacity to take care of these patients.
Conclusions
The results of this study provide compelling evidence that surviving an SAH is more likely if the patient is admitted to a hospital with a high caseload of SAHs. Transfers of patients with SAH from low-caseload to high-caseload hospitals are relatively infrequent. Concentrating treatment for SAH in high-caseload hospitals may decrease the high incidence of mortality associated with transfer. Additional research that explores the specific factors that account for lower mortality rates at centers with high SAH case volumes may provide important insights about how best to treat patients with SAH.
